Albany, NY -- (SBWIRE) -- 01/04/2019 -- Abnormal cell growth can lead to cancer. Cells that grow uncontrollably invade nearby tissues and further spread to other parts of the body through the lymphatic system. Lung cancer, also known as lung carcinoma, is characterized by uncontrolled cell growth in lungs. There are three major types of lung cancer: non-small cell lung cancer, small cell lung cancer, and lung carcinoid tumor. Non-small cell lung cancer is the common type of lung cancer. About 85% of lung cancers are non-small cell lung cancers. Common symptoms of lung cancer include coughing, chest pains, weight loss, and shortness of breath. Lung cancer can be treated through various types of therapies such as chemotherapy, radiation therapy, vaccines, and immunotherapies.
Obtain Report Details @
According to Centers for Disease Control and Prevention (CDC), lung cancer is the primary cause of cancer death and the second most common cancer. The global lung cancer therapeutics market is expected to expand at a rapid pace during the forecast period due to the increase in incidence of lung cancer. Cigarette smoking, pipes, cigar smoking, and constant exposure to asbestos are the key factors that can cause lung cancer. Prominent factors driving the global lung cancer therapeutics market include increase in geriatric population and rise in prevalence of unhealthy lifestyles. Availability of generic drugs, poor cancer diagnostic facilities in many countries, high cost and the adverse effect of radiation and chemotherapies are the factors likely to restrain the global lung cancer therapeutics market during the forecast period.
Request Report Brochure @
The global lung cancer therapeutics market can be segmented based on chemotherapy, targeted therapy, radiotherapy, and geography. Based on chemotherapy, the global lung cancer therapeutics market can be categorized into Gemzar, Alimta, Paraplatin, Taxotere, Navelbine, and others. Chemotherapy is usually based on the combination of drugs. In terms of targeted therapy, the global lung cancer therapeutics market can be divided into Avastin, Tarceva, Iressa, Gilotrif, and others. Based on radiotherapy, the global lung cancer therapeutics market can be segregated into external beam radiotherapy, internal radiotherapy, and systemic radiotherapy.
Enquiry for Discount on this Report @
About Transparency Market Research
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The companyâ€™s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMRâ€™s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
USA - Canada Toll Free: 866-552-3453